Barclays
NBTX

Barclays’s Nanobiotix NBTX Stock Holding History

Barclays’s Portfolio NBTX Stock Details NBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4
Closed -$76 – 5531
2025
Q3 		$76 Hold
4
– – ﹤0.01% 5289
2025
Q2 		$19 Hold
4
– – ﹤0.01% 5144
2025
Q1 		$14 Hold
4
– – ﹤0.01% 5171
2024
Q4 		$11 Sell
4
-106
-96% -$424 ﹤0.01% 5225
2024
Q3 		$633 Hold
110
– – ﹤0.01% 5138
2024
Q2 		$550 Buy
+110
New +$663 ﹤0.01% 4706

Other funds holding NBTX

JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

Barclays's NBTX Position: Q4 2025 in Review

Barclays sold out of Nanobiotix (NBTX) in Q4 2025, closing a stake of 4 shares — an estimated $76 sold.

Barclays first reported a position in NBTX in Q2 2024 and held it in 6 quarters. The position peaked at $633 in Q3 2024. 14 funds tracked by Wall St. Rank hold NBTX as of Q4 2025.

  • Barclays reported no remaining Nanobiotix position as of Q4 2025 after selling out during the quarter.
  • Barclays sold 4 Nanobiotix shares in Q4 2025, an estimated $76.
  • Barclays first reported a position in Nanobiotix in Q2 2024 and held it in 6 quarters.
  • Barclays's Nanobiotix position peaked at $633 in Q3 2024.
  • 14 funds tracked by Wall St. Rank held Nanobiotix as of Q4 2025.

Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.